TY - JOUR
AU - R. Chandler
AU - E. V. Nunes
AU - S. Tan
AU - P. R. Freeman
AU - A . Y. Walley
AU - M. Lofwall
AU - E. Oga
AU - L. Glasgow
AU - J. L. Brown
AU - L. Fanucchi
AU - D. Beers
AU - T. Hunt
AU - R. Bowers-Sword
AU - C. Roeber
AU - T. Baker
AU - T. J. Winhusen
A1 - 
AB - The Helping End Addictions Long Term (HEALing) Communities Study (HCS) seeks to significantly reduce overdose deaths in 67 highly impacted communities in Kentucky (KY), Massachusetts (MA), New York (NY), and Ohio (OH) by implementing evidence-based practices (EBPs) to reduce overdose deaths. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA) organizes EBP strategies under three menus: Overdose Education and Naloxone Distribution (OEND), Medication Treatment for Opioid Use Disorder (MOUD), and Safer Prescribing and Dispensing Practices (SPDP). The ORCCA sets requirements for strategy selection but allows flexibility to address community needs. This paper describes and compiles strategy selection and examines two hypotheses: 1) OEND selections will differ significantly between communities with higher versus lower opioid-involved overdose deaths; 2) MOUD selections will differ significantly between urban versus rural settings. METHODS: Wave 1 communities (n = 33) provided data on EBP strategy selections. Selections were recorded as a combination of EBP menu, sector (behavioral health, criminal justice, and healthcare), and venue (e.g., jail, drug court, etc.); target medication(s) were recorded for MOUD strategies. Strategy counts and proportions were calculated overall and by site (KY, MA, NY, OH), setting (rural/urban), and opioid-involved overdose deaths (high/low). RESULTS: Strategy selection exceeded ORCCA requirements across all 33 communities, with OEND strategies accounting for more (40.8%) than MOUD (35.1%), or SPDP (24.1%) strategies. Site-adjusted differences were not significant for either hypothesis related to OEND or MOUD strategy selection. CONCLUSIONS: HCS communities selected strategies from the ORCCA menu well beyond minimum requirements using a flexible approach to address unique needs.
AD - National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA. Electronic address: redonna.chandler@nih.gov.; Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY, USA.; RTI International, Research Triangle Park, NC, USA.; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY, USA.; Grayken Center for Addiction, Clinical Addiction Research Education Unit, Boston Medical Center Boston, MA, USA.; College of Medicine, University of Kentucky Center on Drug and Alcohol Research, Lexington, KY, USA.; Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA.; Columbia University School of Social Work, 1255 Amsterdam Avenue, New York, NY, USA.; Substance Abuse and Mental Health Services Administration, Rockville, MD, USA.; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
AN - 36780768
BT - Drug Alcohol Depend
C5 - Opioids & Substance Use; Healthcare Disparities
DA - Apr 1
DO - 10.1016/j.drugalcdep.2023.109804
DP - NLM
ET - 20230210
JF - Drug Alcohol Depend
LA - eng
N2 - The Helping End Addictions Long Term (HEALing) Communities Study (HCS) seeks to significantly reduce overdose deaths in 67 highly impacted communities in Kentucky (KY), Massachusetts (MA), New York (NY), and Ohio (OH) by implementing evidence-based practices (EBPs) to reduce overdose deaths. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA) organizes EBP strategies under three menus: Overdose Education and Naloxone Distribution (OEND), Medication Treatment for Opioid Use Disorder (MOUD), and Safer Prescribing and Dispensing Practices (SPDP). The ORCCA sets requirements for strategy selection but allows flexibility to address community needs. This paper describes and compiles strategy selection and examines two hypotheses: 1) OEND selections will differ significantly between communities with higher versus lower opioid-involved overdose deaths; 2) MOUD selections will differ significantly between urban versus rural settings. METHODS: Wave 1 communities (n = 33) provided data on EBP strategy selections. Selections were recorded as a combination of EBP menu, sector (behavioral health, criminal justice, and healthcare), and venue (e.g., jail, drug court, etc.); target medication(s) were recorded for MOUD strategies. Strategy counts and proportions were calculated overall and by site (KY, MA, NY, OH), setting (rural/urban), and opioid-involved overdose deaths (high/low). RESULTS: Strategy selection exceeded ORCCA requirements across all 33 communities, with OEND strategies accounting for more (40.8%) than MOUD (35.1%), or SPDP (24.1%) strategies. Site-adjusted differences were not significant for either hypothesis related to OEND or MOUD strategy selection. CONCLUSIONS: HCS communities selected strategies from the ORCCA menu well beyond minimum requirements using a flexible approach to address unique needs.
PY - 2023
SN - 0376-8716 (Print); 0376-8716
SP - 109804
ST - Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term (SM)) communities study
T1 - Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term (SM)) communities study
T2 - Drug Alcohol Depend
TI - Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term (SM)) communities study
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1016/j.drugalcdep.2023.109804
VL - 245
VO - 0376-8716 (Print); 0376-8716
Y1 - 2023
ER -